Immunohistochemical evidence for the involvement of protein convertases 5A and 2 in the processing of pro-neurotensin in rat brain.
The neuropeptides/neurotransmitters neurotensin (NT) and neuromedin (NN) are synthesized by endoproteolytic cleavage of a common inactive precursor, pro-NT/NN. In vitro studies have suggested that the prohormone convertases PC5A and PC2 might both be involved in this process. In the present study, we used dual immunohistochemical techniques to determine whether either one or both of these two convertases were co-localized with pro-NT/NN maturation products and could therefore be involved in the physiological processing of this propeptide in rat brain. PC2-immunoreactive neurons were present in all regions immunopositive for NT. All but three regions expressing NT were also immunopositive for PC5A. Dual localization of NT with either convertase revealed that NT was extensively co-localized with both PC5A and PC2, albeit with regional differences. These results strongly suggest that PC5A and PC2 may play a key role in the maturation of pro-NT/NN in mammalian brain. The regional variability in NT/PC co-localization patterns may account for the region-specific maturation profiles previously reported for pro-NT/NN. The high degree of overlap between PC5A and PC2 in most NT-rich areas further suggests that these two convertases may act jointly to process pro-NT/NN. At the subcellular level, PC5A was largely co-localized with the mid-cisternae Golgi marker MG-160. By contrast, PC2 was almost completely excluded from MG-160-immunoreactive compartments. These results suggest that PC5A, which is particularly efficient at cleaving the two C-terminal-most dibasics of pro-NT/NN, may be acting as early as in the Golgi apparatus to release NT, whereas PC2, which is considerably more active than PC5A in cleaving the third C-terminal doublet, may be predominantly involved further distally along the secretory pathway to release NN.
Villeneuve
P
P
Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada.
Lafortune
L
L
Seidah
N G
NG
Kitabgi
P
P
Beaudet
A
A
D000818:Animals; D001921:Brain / Q000166:cytology / Q000201:enzymology*; D008297:Male; D009474:Neurons / Q000166:cytology / Q000201:enzymology*; D009496:Neurotensin / Q000378:metabolism*; D010446:Peptide Fragments / Q000378:metabolism; D045706:Proprotein Convertase 2; D045702:Proprotein Convertase 5; D011498:Protein Precursors / Q000378:metabolism*; D051381:Rats / Q000033:anatomy & histology / Q000378:metabolism*; D017207:Rats, Sprague-Dawley; D011956:Receptors, Cell Surface; D017468:Receptors, Fibroblast Growth Factor; D012697:Serine Endopeptidases / Q000378:metabolism*; D012795:Sialoglycoproteins / Q000378:metabolism; D013381:Subtilisins / Q000378:metabolism*
D010446:Peptide Fragments; D011498:Protein Precursors; D011956:Receptors, Cell Surface; D017468:Receptors, Fibroblast Growth Factor; D012795:Sialoglycoproteins; C086711:cysteine-rich fibroblast growth factor receptor; C411471:proneurotensin; D009496:Neurotensin; D045702:Proprotein Convertase 5; D012697:Serine Endopeptidases; D013381:Subtilisins; C473807:propeptide convertase 5, rat; D045706:Proprotein Convertase 2